Literature DB >> 12750336

Drosophila gain-of-function mutant RTK torso triggers ectopic Dpp and STAT signaling.

Jinghong Li1, Willis X Li.   

Abstract

Overactivation of receptor tyrosine kinases (RTKs) has been linked to tumorigenesis. To understand how a hyperactivated RTK functions differently from wild-type RTK, we conducted a genome-wide systematic survey for genes that are required for signaling by a gain-of-function mutant Drosophila RTK Torso (Tor). We screened chromosomal deficiencies for suppression of a gain-of-function mutation tor (tor(GOF)), which led to the identification of 26 genomic regions that, when in half dosage, suppressed the defects caused by tor(GOF). Testing of candidate genes in these regions revealed many genes known to be involved in Tor signaling (such as those encoding the Ras-MAPK cassette, adaptor and structural molecules of RTK signaling, and downstream target genes of Tor), confirming the specificity of this genetic screen. Importantly, this screen also identified components of the TGFbeta (Dpp) and JAK/STAT pathways as being required for Tor(GOF) signaling. Specifically, we found that reducing the dosage of thickveins (tkv), Mothers against dpp (Mad), or STAT92E (aka marelle), respectively, suppressed tor(GOF) phenotypes. Furthermore, we demonstrate that in tor(GOF) embryos, dpp is ectopically expressed and thus may contribute to the patterning defects. These results demonstrate an essential requirement of noncanonical signaling pathways for a persistently activated RTK to cause pathological defects in an organism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750336      PMCID: PMC1462547     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  49 in total

1.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

Authors:  A Sewing; B Wiseman; A C Lloyd; H Land
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  The heat shock protein 83 (Hsp83) is required for Raf-mediated signalling in Drosophila.

Authors:  A van der Straten; C Rommel; B Dickson; E Hafen
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

3.  Two gap genes mediate maternal terminal pattern information in Drosophila.

Authors:  D Weigel; G Jürgens; M Klingler; H Jäckle
Journal:  Science       Date:  1990-04-27       Impact factor: 47.728

4.  Identification of autosomal regions involved in Drosophila Raf function.

Authors:  W Li; E Noll; N Perrimon
Journal:  Genetics       Date:  2000-10       Impact factor: 4.562

5.  Requirement of the Drosophila raf homologue for torso function.

Authors:  L Ambrosio; A P Mahowald; N Perrimon
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

6.  Control and function of terminal gap gene activity in the posterior pole region of the Drosophila embryo.

Authors:  G Brönner; H Jäckle
Journal:  Mech Dev       Date:  1991-11       Impact factor: 1.882

7.  A protein kinase similar to MAP kinase activator acts downstream of the raf kinase in Drosophila.

Authors:  L Tsuda; Y H Inoue; M A Yoo; M Mizuno; M Hata; Y M Lim; T Adachi-Yamada; H Ryo; Y Masamune; Y Nishida
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

8.  Torso, a receptor tyrosine kinase required for embryonic pattern formation, shares substrates with the sevenless and EGF-R pathways in Drosophila.

Authors:  H J Doyle; J M Bishop
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

Review 9.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  An oncogenic form of human raf can specify terminal body pattern in Drosophila.

Authors:  J Casanova; M Llimargas; S Greenwood; G Struhl
Journal:  Mech Dev       Date:  1994-10       Impact factor: 1.882

View more
  8 in total

1.  A directed screen for genes involved in Drosophila blood cell activation.

Authors:  Carl-Johan Zettervall; Ines Anderl; Michael J Williams; Ruth Palmer; Eva Kurucz; Istvan Ando; Dan Hultmark
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

2.  A genetic screen in Drosophila for genes interacting with senseless during neuronal development identifies the importin moleskin.

Authors:  Kathryn L Pepple; Aimée E Anderson; Benjamin J Frankfort; Graeme Mardon
Journal:  Genetics       Date:  2006-11-16       Impact factor: 4.562

Review 3.  Functions and mechanisms of receptor tyrosine kinase Torso signaling: lessons from Drosophila embryonic terminal development.

Authors:  Willis X Li
Journal:  Dev Dyn       Date:  2005-03       Impact factor: 3.780

4.  The Birt-Hogg-Dubé tumor suppressor Folliculin negatively regulates ribosomal RNA synthesis.

Authors:  Kriti Gaur; Jinghong Li; Dakun Wang; Pranabananda Dutta; Shian-Jang Yan; Amy Tsurumi; Hartmut Land; Guan Wu; Willis X Li
Journal:  Hum Mol Genet       Date:  2012-10-16       Impact factor: 6.150

5.  An RNA aptamer perturbs heat shock transcription factor activity in Drosophila melanogaster.

Authors:  H Hans Salamanca; Nicholas Fuda; Hua Shi; John T Lis
Journal:  Nucleic Acids Res       Date:  2011-05-16       Impact factor: 16.971

6.  STAT is an essential activator of the zygotic genome in the early Drosophila embryo.

Authors:  Amy Tsurumi; Fan Xia; Jinghong Li; Kimberly Larson; Russell LaFrance; Willis X Li
Journal:  PLoS Genet       Date:  2011-05-26       Impact factor: 5.917

7.  Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis.

Authors:  Yannan Fan; Sylvie Richelme; Emilie Avazeri; Stéphane Audebert; Françoise Helmbacher; Rosanna Dono; Flavio Maina
Journal:  PLoS Genet       Date:  2015-09-22       Impact factor: 5.917

8.  Genome-Wide Screen for New Components of the Drosophila melanogaster Torso Receptor Tyrosine Kinase Pathway.

Authors:  Alex R Johns; Michelle A Henstridge; Melissa J Saligari; Karyn A Moore; James C Whisstock; Coral G Warr; Travis K Johnson
Journal:  G3 (Bethesda)       Date:  2018-03-02       Impact factor: 3.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.